Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in Women
NCT03630718 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55
Last updated 2025-06-25
Summary
Fatigue is a clinical symptom that has been described as the most disturbing by around 50% of patients with PBC. It has an important impact on patients' quality of life and is associated with an increased mortality risk. To treat fatigue in PBC, only medical treatments have been tested with limited efficacy or serious sides' effects. In other diseases, mostly cancer, psychological interventions showed efficacy on fatigue decrease. Most interventions consist in psychoeducation with: education about fatigue, development of self-care or coping techniques, activity management and learning to balance between activities and rest. Hypnosis, which consists in a body work for psycho-therapeutic use (e.g., through imagination), has also shown promising results. Moreover, psychological intervention efficacy seems to be influenced by patients' characteristics, such as personality. Therefore, the first aim of the present single-center randomized controlled phase 2 trial is to assess the efficacy of a psycho educational intervention and a hypnosis intervention on PBC patients' fatigue to demonstrate that both psychoeducational and hypnosis interventions decrease patient fatigue.
Conditions
- Liver Cirrhosis, Biliary
Interventions
- BEHAVIORAL
-
Psychoeducational Intervention
The psychoeducational intervention will be a structured education programme and will consist of informing patients about fatigue dimensions, aetiology and treatments, by helping them to develop strategies to cope with fatigue better and by teaching them to manage the balance between activities and rest. The construction of the contents of the sessions of this intervention will aim to reduce fatigue via the programme developed by Reif et al. in cancer patients and is composed of 6 sessions of 90 minutes, one session per week. It is a group intervention for 8 patients. For this project, the investigators have reorganised the sessions and their content to fit with an individual format adapted to PBC. This format is more appropriate to take into account the specificity of the manifestation of fatigue for each patient.
- BEHAVIORAL
-
Hypnosis intervention
The hypnosis intervention will consist of decreasing fatigue and the related distress, and increasing feelings of energy and well-being. Therefore, each hypnosis exercise will be audiotaped and given to the patient at the end of the session. Patients will be asked to use these recordings as much as they want to help them to manage fatigue. The techniques used are inspired by those used in chronic pain management and fatigue.
Sponsors & Collaborators
-
University of Paris 5 - Rene Descartes
collaborator OTHER -
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Christophe CORPECHOT, MD · Assistance Publique - Hôpitaux de Paris
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-05-27
- Primary Completion
- 2023-05-17
- Completion
- 2023-05-22
Countries
- France
Study Locations
More Related Trials
-
Study of Obeticholic Acid(OCA) Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)
NCT04956328 ·Status: UNKNOWN ·Phase: PHASE3
-
Monitoring the Response of Combination Ursodiol and Seladelpar Treatment
NCT07122206 ·Status: NOT_YET_RECRUITING
-
Clinical Research of Tapering UDCA in PBC Patients With a Complete Response
NCT04650243 ·Status: RECRUITING ·Phase: PHASE4
-
Ursodiol-Methotrexate for Primary Biliary Cirrhosis
NCT00006168 ·Status: COMPLETED ·Phase: PHASE3
-
Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary Cirrhosis
NCT06715319 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders
NCT02937012 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy
NCT06443606 ·Status: RECRUITING ·Phase: PHASE3
-
Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
NCT05292872 ·Status: COMPLETED
-
A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics
NCT06591468 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
Efficacy of 24 Month of Bezafibrate in Primary Sclerosing Cholangitis With Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy
NCT04309773 ·Status: UNKNOWN ·Phase: PHASE3
-
Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)
NCT06365424 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)
NCT00550862 ·Status: TERMINATED ·Phase: PHASE2
-
Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)
NCT00943176 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis
NCT03394924 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Antiretroviral Therapy (cART) for PBC
NCT03954327 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA
NCT02965911 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis
NCT00004748 ·Status: COMPLETED ·Phase: PHASE3
-
Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1
NCT04618575 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC
NCT05239468 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis
NCT00393185 ·Status: WITHDRAWN ·Phase: PHASE1
-
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study
NCT06755541 ·Status: RECRUITING ·Phase: PHASE3
-
A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
NCT05293938 ·Status: WITHDRAWN
-
Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
NCT05749822 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Pentoxifylline for Primary Biliary Cirrhosis
NCT01249092 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)
NCT04047160 ·Status: COMPLETED ·Phase: PHASE1